What monitoring is required following treatment for persistent pulmonary hypertension of the newborn (PPHN)?

Updated: Sep 03, 2019
  • Author: Kate A Tauber, MD; Chief Editor: Howard S Weber, MD, FSCAI  more...
  • Print


Owing to the high risk of neurodevelopmental impairment and sensorineural hearing loss, infants should be monitored closely for the first 2 years of life, preferably in a specialty follow-up clinic for developmental follow-up care.

The pulmonary hypertension clinic also offers comprehensive evaluation and an individual treatment plan for patients with persistence of any level of pulmonary hypertension.

Recommend complete screening before pediatric patients enter school, to determine if they have any subtle deficits that may predispose them to learning disabilities.

Reassess the infant's hearing when he or she is aged 6 months and again as the results indicate. Late sensorineural hearing loss has been reported in a high percentage of patients.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!